While most studies have shown that PTHrP promotes cancer cell proliferation, tumor progression, and metastasis, one study found that intermittent PTH (1–34) inhibited breast cancer bone metastasis, consistent with the dose- and time-dependent anabolic and metabolic effects of PTHrP in bone [49]. The gene discussed is PTH; the disease is breast cancer.